Carregant...
In silico design of two novel fusion proteins, p28-IL-24 and p28-M4, targeted to breast cancer cells
BACKGROUND AND PURPOSE: An anticancer peptide P28, has shown to be cytolethal on various cancer cells including breast cancer. Moreover, p28 can be also used as a targeting moiety in the structure of fusion proteins. IL-24 (or its truncated form, M4) is a cytokine with anticancer activity against a...
Guardat en:
| Publicat a: | Res Pharm Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer - Medknow
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7306244/ https://ncbi.nlm.nih.gov/pubmed/32582360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1735-5362.283820 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|